Grey Wolf Therapeutics Announces Formation of Clinical Advisory Board in Anticipation of Advancing First-in-Class Immuno-Oncology Approach into the Clinic
- Tuesday, February 15, 2022, 7:04
- Finance
- Add a comment
OXFORD, England, Feb. 15, 2022 /PRNewswire/ — Grey Wolf Therapeutics, a biotechnology company spearheading a new therapeutic approach to immuno-oncology driven by targeted neoantigen generation, today announced the formation of its clinical advisory board featuring distinguished thought…
About the Author
adminasapcorp has written 41850 stories on this site.